HAG.DE Stock Today: January 9 - Defense Rally on Bundeswehr Ammo Deal

HAG.DE Stock Today: January 9 – Defense Rally on Bundeswehr Ammo Deal

Hensoldt stock is in focus today as Germany expands its Puma 30mm ammunition framework with Rheinmetall toward about €1 billion. The Bundeswehr ammunition deal, plus December’s €4.2 billion order for 200 Puma IFVs, strengthens multi‑year procurement visibility and supports German defense stocks. We review how this Rheinmetall order wave can flow through to Hensoldt’s sensors and electronic warfare backlog, today’s key price levels, and what to watch into the next earnings update in late February.

Bundeswehr deal: what matters for Hensoldt

Germany expanded the Puma 30mm ammunition framework to roughly €1 billion, securing several hundred thousand rounds under a multi‑year contract. This deepens the supply pipeline around the Puma platform and supports industrial planning for key suppliers. The framework scale and duration help stabilize revenue outlooks across the chain. ESUT reported the broader framework and scope of the ammunition package source.

While munitions go to Rheinmetall, the increased Puma fleet and training tempo imply sustained demand for sensors, optronics, command systems, and EW support. December’s €4.2 billion order for 200 Puma IFVs underlines multi‑year visibility that can underpin order intake for Hensoldt’s airborne and ground systems. For investors, this expands the pipeline lens beyond one‑off headlines and adds support to Hensoldt stock through potential backlog conversion.

Market snapshot and technicals

Latest ticks show HAG.DE at €82.90, trading between €78.25 and €82.90, with volume of 667,852 versus a 394,951 average. The year range is €33.12 to €116.90. Elevated turnover suggests active positioning on the Bundeswehr ammunition deal and broader defense bid. For near term, keep an eye on liquidity and whether buyers defend the opening area after the initial reaction to the news flow.

Momentum is firm with RSI at 68.96 and ADX at 27.52, signaling a strong, near‑overbought trend. Price is near the Bollinger upper band at €83.21, making that zone a first gauge of strength. The 50‑day average at €76.88 is initial support, while the 200‑day at €85.83 is resistance. ATR at 3.35 points to active ranges, so position sizing matters.

Valuation and quality check

Top‑line growth stands at 21.3% year over year, with EBIT up 25.4% and EPS advancing 82.4%. Margins remain modest for the sector, with gross at 21.5%, operating at 8.9%, and net at 5.2%. The market prices this growth at 80.4x PE and 28.5x EV/EBITDA. This mix argues that execution and order conversion must stay strong to justify the current multiple for Hensoldt stock.

Liquidity is adequate with a 1.22 current ratio. Net debt to EBITDA is 2.81 and interest coverage sits near 2.0, which investors should monitor if rates stay high. Free cash flow per share is €1.66, implying a 1.9% FCF yield, and the dividend yield is about 0.58% with a 46.8% payout. Working capital cycles remain long, typical for complex defense programs.

Peer spotlight: Rheinmetall effect

Rheinmetall’s pipeline continues to expand with the Puma ammunition framework and recent munitions wins, supporting its order book. RHM.DE trades around €1,745 with a day range of €1,680 to €1,752 and reports on 10 March 2026. RP‑Online highlights the Bundeswehr’s large‑scale demand backdrop and investor reaction to the latest award source.

More munitions and vehicle orders strengthen program continuity across the ecosystem, a positive backdrop for German defense stocks. For Hensoldt stock, greater Puma fleet readiness can support sensors, optronics, and support contracts. Still, valuations are full across peers. We will watch fiscal updates, new framework calls, and Hensoldt’s 26 February 2026 earnings for order intake, margin progress, and cash conversion signals.

Final Thoughts

For investors in Germany, the Bundeswehr ammunition deal adds another proof point that the rearmament cycle remains in motion. The expanded Puma framework builds multi‑year visibility, and the December IFV award supports sustained demand for sensors and EW suites. Hensoldt stock benefits from this backdrop, but the valuation already prices solid execution. Focus on three items now: order intake tied to Puma and radar programs, margin discipline versus inflation and supply chains, and cash conversion. Technically, watch €76.90 as trend support and €85.80 as resistance. Near term catalysts include further procurement updates, budget clarity, and Hensoldt’s 26 February 2026 results.

FAQs

Is the Bundeswehr ammunition deal positive for Hensoldt stock?

Yes. While ammunition revenue sits with Rheinmetall, more Puma vehicles in service and training cycles can lift demand for sensors, optronics, support, and upgrades. That supports Hensoldt’s backlog and multi‑year visibility. Execution still matters, so monitor order intake, margins, and cash conversion in upcoming results.

What key levels should I watch on Hensoldt?

Near term, the 50‑day moving average around €76.90 is initial support and the 200‑day near €85.80 is resistance. Price is close to the Bollinger upper band near €83, so consolidation would be normal. With ATR near 3.35, size positions carefully and use stops suited to your risk.

When is Hensoldt’s next earnings date?

Hensoldt is scheduled to report on 26 February 2026. We will look for updates on order intake linked to Puma programs, radar contracts, and export demand, plus margin progress and cash conversion. Guidance on 2026 capital allocation and working capital will also be important.

How does Rheinmetall’s order momentum affect Hensoldt?

Rheinmetall’s munitions and vehicle awards strengthen the Puma program’s continuity, which often drives follow‑on demand for sensors, optronics, and lifecycle support. This backdrop helps Hensoldt’s pipeline. However, both names trade at rich multiples, so results and cash flow will need to confirm the growth path.

Are German defense stocks still attractive after the rally?

The structural budget tailwind and multi‑year programs remain supportive. That said, valuations are elevated. Investors may prefer staged entries, focusing on order momentum, margin discipline, and cash conversion. Watch upcoming earnings, new framework announcements, and budget decisions for fresh signals before adding exposure.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *